These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 6703724

  • 1. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K, Furuta I, Ota K.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [Abstract] [Full Text] [Related]

  • 2. [Cardiotoxicity of mitoxantrone].
    Okuma K, Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3040-5. PubMed ID: 3464231
    [Abstract] [Full Text] [Related]

  • 3. [Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10].
    Tajima M.
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1211-6. PubMed ID: 6471423
    [Abstract] [Full Text] [Related]

  • 4. Prevention by coenzyme Q10 of the electrocardiographic changes induced by adriamycin in rats.
    Choe JY, Combs AB, Folkers K.
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):199-202. PubMed ID: 441512
    [Abstract] [Full Text] [Related]

  • 5. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
    Tsubaki K, Horiuchi A, Kitani T, Taniguchi N, Masaoka T, Shibata H, Yonezawa T, Tsubakio T, Kawagoe H, Shinohara Y.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1420-7. PubMed ID: 6742867
    [Abstract] [Full Text] [Related]

  • 6. [Protective effect of CoQ 10 administration on cardial toxicity in FAC therapy].
    Takimoto M, Sakurai T, Kodama K, Yokoi H, Suzuki Y, Enomoto K, Okada N.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):116-21. PubMed ID: 7184359
    [Abstract] [Full Text] [Related]

  • 7. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
    Wang SQ.
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
    [Abstract] [Full Text] [Related]

  • 8. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
    Okuma K, Furuta I, Ota K.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
    [Abstract] [Full Text] [Related]

  • 9. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
    Conklin KA.
    Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
    [Abstract] [Full Text] [Related]

  • 10. Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat.
    Folkers K, Choe JY, Combs AB.
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5178-80. PubMed ID: 283424
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of ouabain on adriamycin-induced cardiovascular anomalies in chick embryos.
    Takagi Y, Bruyere HJ, Nishikawa T.
    Teratology; 1989 Jun; 39(6):573-80. PubMed ID: 2772843
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group].
    Okuma K, Ariyoshi Y, Wakui A, Ogawa M, Furue H, Niitani H, Shimoyama M, Majima H, Taguchi T, Kimura I.
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1143-9. PubMed ID: 2053773
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD, Ettinger DS, Abeloff MD, Livengood SV, Fortuin NJ.
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [Abstract] [Full Text] [Related]

  • 14. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.
    Cortes EP, Gupta M, Chou C, Amin VC, Folkers K.
    Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863
    [Abstract] [Full Text] [Related]

  • 15. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
    Folkers K, Wolaniuk A.
    Drugs Exp Clin Res; 1985 Jun; 11(8):539-45. PubMed ID: 3836873
    [Abstract] [Full Text] [Related]

  • 16. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
    Shah SA, Sander S, Cios D, Lipeika J, Kluger J, White CM.
    Ann Pharmacother; 2007 Mar; 41(3):420-5. PubMed ID: 17341532
    [Abstract] [Full Text] [Related]

  • 17. [Platelet aggregation and coenzyme Q10 content in platelets in cancer patients].
    Shinkai T, Tominaga K, Shimabukuro Z, Shimizu E, Eguchi K, Saijo N, Iwashita K, Niitani H.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):87-96. PubMed ID: 6230057
    [Abstract] [Full Text] [Related]

  • 18. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.
    Rosenfeldt F, Marasco S, Lyon W, Wowk M, Sheeran F, Bailey M, Esmore D, Davis B, Pick A, Rabinov M, Smith J, Nagley P, Pepe S.
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):25-32. PubMed ID: 15632821
    [Abstract] [Full Text] [Related]

  • 19. [Effect of biological membrane stabilizing drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on adriamycin (doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice].
    Shinozawa S, Kawasaki H, Gomita Y.
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):93-8. PubMed ID: 8546477
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA, Brereton HD, Rodbard D.
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.